|
1
|
Xu M, Zhang YY, Wang HF and Yang GS: The
expression and function of miRNA-106 in pediatric osteosarcoma. Eur
Rev Med Pharmacol Sci. 21:715–722. 2017.PubMed/NCBI
|
|
2
|
Hua Y, Jin Z, Zhou F, Zhang YQ and Zhuang
Y: The expression significance of serum MiR-21 in patients with
osteosarcoma and its relationship with chemosensitivity. Eur Rev
Med Pharmacol Sci. 21:2989–2994. 2017.PubMed/NCBI
|
|
3
|
Gao KT and Lian D: Long non-coding RNA
MALAT1 is an independent prognostic factor of osteosarcoma. Eur Rev
Med Pharmacol Sci. 20:3561–3565. 2016.PubMed/NCBI
|
|
4
|
Tang B, Liu C, Zhang QM and Ni M:
Decreased expression of miR-490-3p in osteosarcoma and its clinical
significance. Eur Rev Med Pharmacol Sci. 21:246–251.
2017.PubMed/NCBI
|
|
5
|
Chang CC, Hung CM, Yang YR, Lee MJ and Hsu
YC: Sulforaphane induced cell cycle arrest in the G2/M phase via
the blockade of cyclin B1/CDC2 in human ovarian cancer cells. J
Ovarian Res. 6:412013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Choi HJ, Fukui M and Zhu BT: Role of
cyclin B1/Cdc2 up-regulation in the development of mitotic
prometaphase arrest in human breast cancer cells treated with
nocodazole. PLoS One. 6:e243122011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen X, Liao Y, Long D, Yu T, Shen F and
Lin X: The Cdc2/Cdk1 inhibitor, purvalanol A, enhances the
cytotoxic effects of taxol through Op18/stathmin in non-small cell
lung cancer cells in vitro. Int J Mol Med. 40:235–242. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu D, Chen K, Bai Y, Zhu X, Chen Z, Wang
C, Zhao Y and Li M: Screening of diagnostic markers for
osteosarcoma. Mol Med Rep. 10:2415–2420. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang B, Leng C, Wu C, Zhang Z, Dou L, Luo
X, Zhang B and Chen X: Smad4 sensitizes colorectal cancer to
5-fluorouracil through cell cycle arrest by inhibiting the
PI3K/Akt/CDC2/survivin cascade. Oncol Rep. 35:1807–1815. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Motoyama K, Inoue H, Mimori K, Tanaka F,
Kojima K, Uetake H, Sugihara K and Mori M: Clinicopathological and
prognostic significance of PDCD4 and microRNA-21 in human gastric
cancer. Int J Oncol. 36:1089–1095. 2010.PubMed/NCBI
|
|
11
|
Zhang J, Wang D, Xiong J, Chen L and Huang
J: MicroRNA-33a-5p suppresses growth of osteosarcoma cells and is
downregulated in human osteosarcoma. Oncol Lett. 10:2135–2141.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao XF, Zhao MY, Chai L, Kukuruga D, Tan
M and Stass SA: Amplified RPS6KB1 and CDC2 genes are potential
biomarkers for aggressive HIV+/EBV+diffuse large B-cell lymphomas.
Int J Clin Exp Pathol. 6:148–154. 2013.PubMed/NCBI
|
|
13
|
Mou S, Wang G, Ding D, Yu D, Pei Y, Teng S
and Fu Q: Expression and function of PIM kinases in osteosarcoma.
Int J Oncol. 49:2116–2126. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma YC, Su N, Shi XJ, Zhao W, Ke Y, Zi X,
Zhao NM, Qin YH, Zhao HW and Liu HM: Jaridonin-induced G2/M phase
arrest in human esophageal cancer cells is caused by reactive
oxygen species-dependent Cdc2-tyr15 phosphorylation via
ATM-Chk1/2-Cdc25C pathway. Toxicol Appl Pharmacol. 282:227–236.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
O'Connell MJ, Lavery I, Yothers G, Paik S,
Clark-Langone KM, Lopatin M, Watson D, Baehner FL, Shak S, Baker J,
et al: Relationship between tumor gene expression and recurrence in
four independent studies of patients with stage II/III colon cancer
treated with surgery alone or surgery plus adjuvant fluorouracil
plus leucovorin. J Clin Oncol. 28:3937–3944. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma C, Zhang Z, Cui Y, Yuan H and Wang F:
Silencing FAT10 inhibits metastasis of osteosarcoma. Int J Oncol.
49:666–674. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qiao Q, Jiang Y and Li G: Curcumin
enhances the response of non-Hodgkin's lymphoma cells to ionizing
radiation through further induction of cell cycle arrest at the
G2/M phase and inhibition of mTOR phosphorylation. Oncol Rep.
29:380–386. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jansen MP, Reijm EA, Sieuwerts AM,
Ruigrok-Ritstier K, Look MP, Rodríguez-González FG, Heine AA,
Martens JW, Sleijfer S, Foekens JA, et al: High miR-26a and low
CDC2 levels associate with decreased EZH2 expression and with
favorable outcome on tamoxifen in metastatic breast cancer. Breast
Cancer Res Treat. 133:937–947. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fletcher CDM, Bridge JA, Hogendoorn PCW,
Hogendoorn PC, Merterns F and Hogendoom P: WTO classification of
tumours of soft tissue and bone. IARC Press. 46:95–104. 2013.
|
|
20
|
Okita Y, Narita Y, Miyakita Y, Ohno M,
Matsushita Y, Fukushima S, Sumi M, Ichimura K, Kayama T and Shibui
S: IDH1/2 mutation is a prognostic marker for survival and predicts
response to chemotherapy for grade II gliomas concomitantly treated
with radiation therapy. Int J Oncol. 41:1325–1336. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Leijen S, Beijnen JH and Schellens JH:
Abrogation of the G2 checkpoint by inhibition of Wee-1 kinase
results in sensitization of p53-deficient tumor cells to
DNA-damaging agents. Curr Clin Pharmacol. 5:186–191. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hong BS, Cho JH, Kim H, Choi EJ, Rho S,
Kim J, Kim JH, Choi DS, Kim YK, Hwang D and Gho YS: Colorectal
cancer cell-derived microvesicles are enriched in cell
cycle-related mRNAs that promote proliferation of endothelial
cells. BMC Genomics. 10:5562009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Malumbres M: Physiological relevance of
cell cycle kinases. Physiol Rev. 91:973–1007. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wilkinson S, Croft DR, O'Prey J,
Meedendorp A, O'Prey M, Dufès C and Ryan KM: The cyclin-dependent
kinase PITSLRE/CDK11 is required for successful autophagy.
Autophagy. 7:1295–1301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lv TZ and Wang GS: Antiproliferation
potential of withaferin A on human osteosarcoma cells via the
inhibition of G2/M checkpoint proteins. Exp Ther Med. 10:323–329.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chae SW, Sohn JH, Kim DH, Choi YJ, Park
YL, Kim K, Cho YH, Pyo JS and Kim JH: Overexpressions of Cyclin B1,
cdc2, p16 and p53 in human breast cancer: The clinicopathologic
correlations and prognostic implications. Yonsei Med J. 52:445–453.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang JQ, Liu HX, Liang Z, Sun YM and Wu M:
Over-expression of p53, p21 and Cdc2 in histologically negative
surgical margins is correlated with local recurrence of laryngeal
squamous cell carcinoma. Int J Clin Exp Pathol. 7:4295–4302.
2014.PubMed/NCBI
|
